Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 73% ± 20% | |
oligodendrocyte precursor cell | 16 studies | 73% ± 23% | |
astrocyte | 15 studies | 48% ± 22% | |
glutamatergic neuron | 13 studies | 85% ± 18% | |
GABAergic neuron | 11 studies | 79% ± 22% | |
microglial cell | 10 studies | 45% ± 22% | |
smooth muscle cell | 8 studies | 35% ± 17% | |
neuron | 7 studies | 56% ± 20% | |
endothelial cell | 7 studies | 47% ± 23% | |
interneuron | 7 studies | 78% ± 26% | |
adipocyte | 7 studies | 27% ± 7% | |
amacrine cell | 6 studies | 73% ± 28% | |
fibroblast | 6 studies | 32% ± 10% | |
pericyte | 5 studies | 28% ± 16% | |
retina horizontal cell | 5 studies | 68% ± 28% | |
type I pneumocyte | 5 studies | 24% ± 2% | |
granule cell | 4 studies | 81% ± 16% | |
retinal cone cell | 4 studies | 66% ± 23% | |
retinal ganglion cell | 4 studies | 90% ± 7% | |
type II pneumocyte | 4 studies | 18% ± 1% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 65% ± 8% | |
GABAergic interneuron | 3 studies | 88% ± 12% | |
glial cell | 3 studies | 52% ± 27% | |
progenitor cell | 3 studies | 49% ± 12% | |
mesothelial cell | 3 studies | 55% ± 18% | |
GABAergic amacrine cell | 3 studies | 77% ± 7% | |
OFF-bipolar cell | 3 studies | 70% ± 8% | |
ON-bipolar cell | 3 studies | 40% ± 24% | |
glycinergic amacrine cell | 3 studies | 85% ± 8% | |
ependymal cell | 3 studies | 50% ± 19% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5244.28 | 2642 / 2642 | 97% | 14.03 | 682 / 705 |
breast | 30% | 199.18 | 138 / 459 | 81% | 3.11 | 900 / 1118 |
thymus | 69% | 428.52 | 449 / 653 | 36% | 0.73 | 218 / 605 |
blood vessel | 87% | 661.64 | 1158 / 1335 | 0% | 0 | 0 / 0 |
ovary | 41% | 347.33 | 73 / 180 | 45% | 0.90 | 194 / 430 |
adrenal gland | 17% | 78.84 | 44 / 258 | 63% | 2.03 | 146 / 230 |
kidney | 11% | 56.65 | 10 / 89 | 67% | 2.00 | 601 / 901 |
prostate | 18% | 123.14 | 45 / 245 | 40% | 0.64 | 200 / 502 |
intestine | 41% | 222.93 | 399 / 966 | 2% | 0.03 | 8 / 527 |
uterus | 31% | 153.73 | 53 / 170 | 9% | 0.20 | 43 / 459 |
skin | 0% | 0.78 | 3 / 1809 | 29% | 1.33 | 138 / 472 |
esophagus | 23% | 107.94 | 334 / 1445 | 4% | 0.09 | 7 / 183 |
bladder | 19% | 93.90 | 4 / 21 | 3% | 0.09 | 14 / 504 |
stomach | 10% | 44.10 | 36 / 359 | 5% | 0.08 | 14 / 286 |
muscle | 15% | 71.32 | 119 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 10% | 0.21 | 39 / 406 |
eye | 0% | 0 | 0 / 0 | 9% | 0.33 | 7 / 80 |
pancreas | 0% | 0 | 0 / 328 | 8% | 0.35 | 14 / 178 |
lung | 0% | 1.33 | 2 / 578 | 7% | 0.14 | 79 / 1155 |
adipose | 6% | 28.00 | 74 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
heart | 1% | 5.74 | 12 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0015030 | Cellular component | Cajal body |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0043197 | Cellular component | dendritic spine |
GO_0005886 | Cellular component | plasma membrane |
GO_0014069 | Cellular component | postsynaptic density |
GO_0046875 | Molecular function | ephrin receptor binding |
Gene name | ANKS1B |
Protein name | Putative ankyrin repeat and sterile alpha motif domain containing 1B Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1) Ankyrin repeat and sterile alpha motif domain containing 1B |
Synonyms | |
Description | FUNCTION: Isoform 2 may participate in the regulation of nucleoplasmic coilin protein interactions in neuronal and transformed cells.; FUNCTION: Isoform 3 can regulate global protein synthesis by altering nucleolar numbers. .; FUNCTION: Isoform 4 may play a role as a modulator of APP processing. Overexpression can down-regulate APP processing. |
Accessions | ENST00000549493.6 [Q7Z6G8-3] ENST00000551613.5 R4GN07 ENST00000552748.5 ENST00000546364.7 R4GMN5 ENST00000552407.5 R4GN78 H0YI72 A0A804HKX1 ENST00000549797.5 ENST00000547776.6 [Q7Z6G8-1] ENST00000547010.5 [Q7Z6G8-6] R4GMS8 ENST00000683438.2 F8VR14 H0YJZ1 B1VKB5 R4GNJ0 ENST00000546960.5 [Q7Z6G8-4] ENST00000341752.11 [Q7Z6G8-9] R4GN70 R4GN73 F8VVQ4 R4GMQ4 ENST00000546568.5 [Q7Z6G8-2] ENST00000550778.5 ENST00000547446.5 [Q7Z6G8-10] ENST00000333732.11 ENST00000548447.1 ENST00000549558.6 [Q7Z6G8-7] ENST00000550693.6 [Q7Z6G8-5] ENST00000549025.6 [Q7Z6G8-8] ENST00000547362.5 ENST00000551560.5 Q7Z6G8 ENST00000549866.5 ENST00000555119.1 |